#ers-genomics

ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery

Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India, May 13, 2026 /PRNewswire/ -- ERS Genomics Limi…